title: [The therapeutic results in acute myeloid leukemias in elderly patients].
authors.forename: E N
authors.initials: EN
authors.lastname: Parovichnikova
authors.forename: V G
authors.initials: VG
authors.lastname: Savchenko
authors.forename: V G
authors.initials: VG
authors.lastname: Isaev
authors.forename: L Iu
authors.initials: LIu
authors.lastname: Tikhonova
authors.forename: T G
authors.initials: TG
authors.lastname: Sarycheva
authors.forename: S M
authors.initials: SM
authors.lastname: Kulikov
mesh_terms: D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D012074:Remission Induction; D013997:Time Factors
chemical_list: D003561:Cytarabine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D003630:Daunorubicin
vernacular_title: Rezul'taty terapii ostrykh mieloidnykh leĭkozov u pozhilykh bol'nykh.